We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PDSB market cap is 64.34M. The company's latest EPS is USD -1.1479 and P/E is -1.49.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.52M | -10.41M | -10.1M | -8.69M | -10.18M |
| Net Income | -10.85M | -10.9M | -10.6M | -8.33M | -10.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.04M | -14.9M | -21.44M | -41.67M | -43.05M |
| Net Income | -7M | -14.85M | -16.92M | -40.86M | -42.94M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 57.19M | 59.39M | 69.01M | 60.5M | 52.45M |
| Total Liabilities | 32.7M | 33.26M | 31.82M | 29.58M | 30.45M |
| Total Equity | 24.48M | 26.13M | 37.18M | 30.92M | 22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.49M | 30.89M | 67.2M | 77.01M | 59.39M |
| Total Liabilities | 2.79M | 3.76M | 3.99M | 33.01M | 33.26M |
| Total Equity | 11.7M | 27.13M | 63.21M | 44M | 26.13M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -25.18M | -33.64M | -9.94M | -18.8M | -26.8M |
| Investing | N/A | N/A | N/A | -29k | -29k |
| Financing | 5.61M | 16.38M | 20.01M | 20M | 20.02M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.07M | -13.15M | -12.49M | -25.71M | -33.64M |
| Investing | 29.38M | N/A | N/A | N/A | N/A |
| Financing | 750k | 29.83M | 48.89M | 34.29M | 16.38M |
| Market Cap | 64.34M |
| Price to Earnings Ratio | -1.49 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.13 |
| Price to Book Ratio | 2.45 |
| Dividend Yield | - |
| Shares Outstanding | 37.41M |
| Average Volume (1 week) | 383.58k |
| Average Volume (1 Month) | 372.79k |
| 52 Week Change | -65.39% |
| 52 Week High | 6.68 |
| 52 Week Low | 1.53 |
| Spread (Intraday) | 0.01 (0.58%) |
| Company Name | PDS Biotechnology Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.pdsbiotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
